Filing Details
- Accession Number:
- 0001179110-16-028708
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-16 14:00:48
- Reporting Period:
- 2016-08-15
- Filing Date:
- 2016-08-16
- Accepted Time:
- 2016-08-16 14:00:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1537768 | A. Daniel Macuga | 3838 West Parkway Blvd. Salt Lake City UT 84120 | Chief Communications Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-08-15 | 1,267 | $57.62 | 1,267 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-08-15 | 1,267 | $132.15 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2016-08-15 | 8,352 | $57.62 | 8,352 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-08-15 | 8,352 | $131.13 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Settled Stock Appreciation Rights | Disposition | 2016-08-15 | 2,249 | $0.00 | 2,249 | $57.62 |
Common Stock | Stock Settled Stock Appreciation Rights | Disposition | 2016-08-15 | 15,001 | $0.00 | 15,001 | $57.62 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
32,251 | 2016-08-15 | 2018-03-15 | No | 4 | M | Direct |
17,250 | 2016-08-15 | 2018-03-15 | No | 4 | M | Direct |
Footnotes
- The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights diisclosed in Table-II
- Weighted average price of $132.1487. Price range in multiple transaction was $132 to $132.53 inclusively.
- Weighted average price of $131.1301. Price range in multiple transaction was $130.885 to $131.6 inclusively.